SPR519

Overview

SPR519 is a selective, orally active dual PI3Kα / mTOR kinase inhibitor, with an IC 50 of 0.03 μM against PI3Kα and an IC 50 of 0.01 μM against mTOR . SPR519 exhibits anticancer effects in ovarian cancer and colon cancer xenograft models. SPR519 can be used for the research of solid tumors (ovarian cancer , colon cancer ).

Application

Products | Products > Disease Areas > Ovarian Cancer | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Cancer | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Colorectal Cancer | Products > Disease Areas > Digestive System Cancer | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > PI3K | Products > Signaling Pathways > mTOR

Product Information

• Catalog No.: HY-156484
• CAS No.: 1391923-59-3
• Molecular Formula: C19H21N7O3S
• Molecular Weight: 427.48
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source